University of the French West Indies and French Guiana Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02562482
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Clinical Investigation Center of French West Indies and French Guiana | University of the French West Indies and French Guiana

Active Ingredients

Drugs in Phase 2 Trials (2)

vrc-chkvlp059-00-vp (1 trial)

vrc-pbspla043-00-vp (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chikungunya Fever (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2